First Protein Degrader Tested Outside Oncology Yields Promising Results

Submitted by admin on December 14, 2022 - 7:23pm

Source:

BioSpace

News Tags:

Kymera Therapeutics

Sanofi

protein degradation

hidradenitis suppurativa

atopic dermatitis

KT-474

Headline:

First Protein Degrader Tested Outside Oncology Yields Promising Results

snippet:

Kymera and Sanofi shared positive results for an IRAK4 degrader for hidradenitis suppurativa (HS) and atopic dermatitis (AD), breaking ground to take protein degradation outside the field of oncology and into inflammatory disease indications.

Search form

You are here

First Protein Degrader Tested Outside Oncology Yields Promising Results

First Protein Degrader Tested Outside Oncology Yields Promising Results